Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Article	Citations
PO1_20. Midtrimester drop in bp is not associated with a decreased risk for hypertensive disorder of pregnancy in a nulliparous cohort	595
PO6_15. Predictive utility for preeclampsia of the SFLT-1/PLGF ratio test in routine clinical practice: a retrospective analysis of 1,397 pregnancies with suspected pre-eclampsia	142
PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a	43
PO8_1. CANCELLED : Predictive value of longitudinal maternal serum angiogenic marker assessment for maternal adverse outcomes in pregnancies with preeclampsia	33
OP14_5. Metformin to prolong pregnancy in preterm preeclampsia	28
O-001. Acute cardiovascular and hemodynamic consequences of placental growth factor administration in guinea pigs	22
OP15_4. A biopolymer-fused form of placental growth factor for treatment of preeclampsia	22
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to lett	20
PS-1. Future interaction among International Society of Hypertension (ISH), Japan Society of Hypertension (JSH) and ISSHP	19
Exploring proteomics in the search of novel predictive cardiovascular biomarkers for preeclampsia	18
P-002. Evidence of neuroinflammation and injured blood–brain-barrier in eclampsia	18
Comparison of subfoveal choroidal thickness in patients with hypertensive disorder of pregnancy versus normotensive pregnant women in third trimester of pregnancy	17
GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran	16
New 3D cardiac in vitro models for assessing the maternal cardiovascular health five years post hypertensive disorders of pregnancy	16
Six-week blood pressure trends in postpartum patients utilizing remote patient monitoring program	16
Examining changes in clinical management and postpartum readmissions for hypertensive disorders of pregnancy over time	16
Comparison of Zuspan regimen and its 12-hour modification in women with severe pre-eclampsia and eclampsia in two hospitals in Abeokuta	15
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial	14
Sociodemographic risk factors associated with patient follow-up after implementation of a CardioObstetrics program	14
PO2_08. decreased sodium (NA + ) buffer capacity in pregnancy and in women following pre-eclampsia	13
Reduced urinary angiotensinogen excretion in preeclampsia	13
Diagnostic accuracy of urine dipstick tests for proteinuria in pregnant women suspected of preeclampsia: A systematic review and meta-analysis	13
Cardiometabolic health 8–12 years after pre-eclampsia: Role of obesity and gestational diabetes (FINNCARE study)	13
Short communication: Is there any benefit of initiating aspirin before the 11th week of gestation?	13
Alterations in the metabolic status of amino acids in newborns of pre-eclampsia women	13

P-059. Prevalence and risk analysis of early-onset and late-onset of hypertensive disorders of pregnancy	12
PO7_3. Patient perception of home blood pressure monitoring kits	12
Response to letter to the editor	11
P-097. Exploring education preferences of Australian women and healthcare providers regarding long-term health after hypertensive disorders of pregnancy – A qualitative rerspective	11
WITHDRAWN: COVID-19 not hypertension or diabetes increases the risk of preeclampsia among a high-risk population	10
Management of hypertension in the early postpartum: A randomized controlled trial	10
Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia	10
Association of MTHFR C677T and A1298C variants with preeclampsia risk and angiogenic imbalance in Tunisian women	10
Extended postpartum outcomes with systematic treatment of and management of postpartum hypertension program	10
The sFLT-1/PlGF ratio versus biochemical parameters in prediction of adverse outcomes in preeclamptic women	10
Letter to the editor: Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	9
P-050. Potency of Tokishakuyakusan in treating preeclampsia: Drug repositioning method by in vitro screening of the Kampo library	9
SY2-3. The role of autophagy in pathophysiology of PE	9
P-023. Uterine vascular resistance and other maternal factors associated with the risk of developing hypertension during pregnancy	9
SY3-1. Long-term consequences of pregnancy complications: lessons from mouse models	9
SY5-1. Timing of delivery in late preterm pre-eclampsia	9
Perinatal outcomes and their determinants among women with eclampsia and severe preeclampsia in selected tertiary hospitals, Eastern Ethiopia	9
P-026. Association between vascular remodeling biomarkers and the placentary bed in pre-eclampsy	9
GS-4. Epidemiology of preeclampsia	9
PO4_2. Genome-wide association study sheds more light on the pathophysiology of preeclampsia	8
P-104. Clinical characteristics and sequelae of intrapartum hypertension	8
OP14_4. Epigenetic regulation by STOX1 in trophoblast cells lines	8
P-017. The Elecsys sFlt-1/PlGF ratio for short-term prediction of preeclampsia in the Japanese cohort of the PROGNOSIS Asia study: Economic evaluation	8
PO9_05. Endothelial glycocalyx dysfunction in early- and late-onset preeclampsia	8
O-005. Circulating biomarkers for neurological complications in preeclampsia	8
Rubidium – Initial observations of an enigmatic element in pre-eclampsia	7
Association between serum NfL and NfH with Antepartum and Postpartum Hypertension	7
Validation of the fullPIERS model in a tertiary hospital in southern Brazil	7
Peripartum antihypertensive use and the risk of neonatal hypoglycemia and postpartum uterine atony: a retrospective cohort study	7
Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia	7
Case of chorioamnionitis in ANA positive in second trimester of pregnancy	7
Validation of urinary Congo Red preeclampsia detection point-of-care devise	7
Effect of positioning on blood pressure measurement in pregnancy	7
Home blood pressure monitoring and mobile health application practices among pregnant persons with and at risk of hypertensive disorders of pregnancy	7
Neuroimaging in eclampsia: A window into the correlates between neural pathology and maternal outcomes	7
Proteinuria in severe preeclampsia: Clinical significance in modern obstetrics	7
Smaller decrease in late second trimester blood pressure is associated with gestational hypertensive disease development	7
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study	7
PO7_1. Patient perceptions regarding remote patient monitoring for postpartum hypertension	7
Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy	6
P-034. Decreased circulating levels of plasmacytoid dendritic cells in women with early-onset preeclampsia	6
PO2_07. Metabolic outcomes in women six months and two years after hypertensive versus normotensive pregnancy – a P4 study	6
PO3_11. Elective anticipation of delivery in preeclampsia with cervical preparation by prostaglandins: success for vaginal delivery	6
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia	6
Maternal bradycardia heralding deteriorating HELLP syndrome (pregnancy hypertension)	6
Y-004. Investigating nitrate metabolism and the oral microbiome in hypertensive pregnancies	6
PO2_14. Impact of previous hypertensive disorders during pregnancy on long-term cardiovascular consequences in women with severe hypertension	6
SY4-4. Role of sFlt-1 on the development of preeclampsia: basic and clinical approach	6
History of IgA vasculitis with nephropathy (Henoch-Schonlein purpura nephritis) can be a strong risk factor for preeclampsia	6
P-009. Associations between circulating sFlt-1 and PlGF and preeclampsia with severe maternal complications, or eclampsia	6

P-103. Incidence and clinical characteristics of hypotension in pregnancy	6
PO3_09. Inhibition of arginase and supplementation with folic acid decrease ROS production in endothelial cells incubated with plasma from preeclampsia pregnant	6
The P4 Study: 6 months postpartum body composition in normotensive vs hypertensive pregnancies	6
Corrigendum to “Down-regulation of B2R contributes to preeclampsia by inhibiting human trophoblast cell invasion and angiogenesis” [Pregnancy Hypertens. 21 (2020) 14–22]	5
PO7_4. Short animated videos aimed at the greatest number of women, to allow and promote self-care in preeclampsia	5
Novel electronic health records applied for prediction of pre-eclampsia: Machine-learning algorithms	5
Exposure to higher concentrations of exogenous ELABELA causes HTR-8/SVneo trophoblast cell dysfunction: A possible pathogenesis of pre-eclampsia	5
PLGF – A pioneer in prediction of pre - eclampsia	5
PO6_06. Soluble endoglin versus SFLT-1/PLGF ratio: detection of preeclampsia, hellp syndrome and FGR in a high-risk cohort	5
PO1_04. Innovative use of Robson classification to understand prevalence of preeclampsia: findings from a Brazilian survey	5
PO9_13. Towards ‘the best method to determine proteinuria’ in pregnant women	5
Validation of the Finnish Care register for Health Care diagnoses for preeclampsia, gestational diabetes and preterm delivery	5
First trimester preeclampsia screening and risk of placental lesions	5
The unintended consequences of modernity: Pollution and its effect on reproductive, maternal and fetal health	5
PO6_21. The utility of the SFLT-1/PLGF ratio among patients with or without hypertension who are suspected of having preeclampsia	5
Perfluorooctane sulfonic acid increases blood pressure and disrupts vascular function and placental steroidogenesis in pregnant rats	5
Determining the relationship between severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia	5
Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia	5
Nifedipine outperforms labetalol: A comparative analysis of hypertension management in black pregnancies	5
P-056. Profound changes in hemodynamics proving late-onset PE being of maternal origin	4
OP04_5. Risk for cardiovascular and cerebrovascular diseases in women during first ten years after pre-eclampsia pregnancy in the FINNPEC study	4
PO6_20. The SFLT-1/PLGF ratio for the prediction of preeclampsia-related adverse fetal and maternal outcomes in women with preexisting diabetes	4
Assessing the Mediterranean diet adherence during pregnancy: Practical considerations based on the associations with cardiometabolic risk	4
SY5-3. Maternal mortality: how can lives are saved?	4
Editorial Board	4
OP08_2. New generation antiplatelet therapies decrease soluble FMS-like tyrosine kinase-1, enhance antioxidant cytoprotection, rescue vascular and endothelial dysfunction and decrease hypertension in	4
Persistence of abnormal uterine artery flow postpartum: Case-control study	4
P-031. Vitamin D maintains viability and decreases apoptosis in huvec and modulates inflammation in placenta from preeclamptic women cultured with TNF-α	4
Women’s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia	4
PO8_4. Late postpartum eclampsia with multifocal posterior reversible encephalopathy syndrome after twin gestation: a case report	4
PO1_03. Individual, social, and environmental risk factors for hypertensive disorders of pregnancy in Ghana: A systematic review	4
SY1-2. COMT in the biology of preeclampsia	4
Increased adherence to ACOG diagnostic guidelines for HDP following a workshop in Bolivia, a LMIC	3
PO8_3. Investigating the role of biomarkers (SFLT-1/PLGF) in cases of covid-19 and its use to distinguish preeclampsia and guide clinical management	3
OP05_4. Umbilical cord plasma from women with pre-eclampsia reduces brain endothelial cell migration involving alterations in the VEGFR2-COFILIN-F-ACTIN polymerization pathway	3
SC3_3. FKBPL signalling in placental development and preeclampsia	3
Association of pre-pregnancy subclinical insulin resistance with cardiac dysfunction in healthy nulliparous women	3
First trimester screening (FTS) for placental pathology – Comparison of the efficacy of different methods	3
Diagnostic challenges of Thrombotic Microangiopathy (TMA) in a pregnant woman remote from term and a case report of atypical TTP	3
PO1_16. Changes in early pregnancy blood pressure among nulliparas that developed a hypertensive disorder of pregnancy	3
Impact of Maternal Early Warning Trigger (MEWT) tool on the incidence of eclampsia	3
P-035. Behavioral risk factors of cardiovascular diseases in pregnant women. Prevalence and socioeconomic predictors in Burkina Faso: a cross-sectional study	3
Barriers and facilitators for adequate calcium intake during pregnancy: A mixed methods study	3
Preeclampsia and eclampsia: Its burden and distribution across facilities in Ethiopia	3
Welcome Message by Congress Chair of ISSHP 2021	3
P-106. COVID-19 and pre-eclampsia: a literature review	3
Preeclampsia in women with lupus – Influence of aspirin and hydroxychloroquine on pregnancy outcome	3
PO1_19. Maternal Mortality from Hypertension in Pregnancy in Brazil from 2015 to 2019	3
A study of long-term prognosis after delivery in patients with hypertensive disorders of pregnancy	3
A multi-ancestry genome-wide association study identifies novel candidate loci near the RARB gene associated with hypertensive disorders of pregnancy in the personalized environment and genes study	3
PO3_10. CANCELLED : A randomized controlled trial comparing low doses of aspirin in the prevention of preeclampsia (ASAPP): the first 100 patients	3
Maternal pulmonary hypertension and cardiopulmonary outcomes during delivery hospitalization in the United States: A nationwide study from 2016–2020	3
SY6-2. Possible role of statin to prevent preeclampsia	3
OP15_5. Metformin to treat preeclampsia: mechanism of action influences mitochondrial dynamics	3
Signs or symptoms of suspected preeclampsia – A retrospective national database study of prevalence, costs, and outcomes	3
Reference-range of arterial stiffness by cardio-ankle vascular index in normal pregnancy	3
Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy	3
OP05_5. Characterization of prokineticins receptors anatagonization in preeclampsia: in vitro and in vivo studies	3
Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?	3
Hypertensive disorders of pregnancy in women with autoimmunity: A rising incidence?	3
Uterine artery doppler as prognostic indicator in Fetal growth restriction in third trimester	3
Eplerenone: A candidate drug to mitigate long-term maternal vascular dysfunction following preeclampsia	3
PO2_06. Lymphatic mimicry of endothelial cells in utero-placental spiral arteries is impaired by overexpression of HSFLT1 in a murine model for preeclampsia	3
Residual liver stiffness in the postpartum period in women with preeclampsia and healthy women: A case-control study	3
P-088. Aspirin and the risk of birthing a small for gestational age infant; A Swedish population-based study	3
Impact of antenatal SARS-CoV-2 infection on development of hypertensive disorders of pregnancy in a large, diverse, cohort	3
Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-contr	3
Clinical manifestations and complications of preeclampsia and eclampsia in populations residing at high altitudes and very high altitudes: A scoping review	2
A tribute to Christopher Redman, MB, BChir, FRCP, FRCOG (ad eundum)	2
Cardiovascular remodelling and reverse remodelling during pregnancy and postpartum: Looking at the right side	2
Perspectives of Ghanaian pregnant women on family involvement in home blood pressure Monitoring: A qualitative analysis	2
Cardiovascular mortality risk a decade after twin and singleton pregnancies complicated by hypertensive disorders of pregnancy	2
PO9_07. CANCELLED : Grading the severity of early-onset preeclampsia using parameters considered for indication for delivery: a Delphi consensus	2
No association in maternal serum levels of TMAO and its precursors in pre-eclampsia and in non-complicated pregnancies	2
Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states	2
Y-017. SAFE@HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia – A case-control study	2
Cardiovascular morbidity and mortality following hypertensive disorders of pregnancy	2
SY2-1. Enhanced adenosine signaling in the placenta: a crucial pathogenic factor and a possible therapeutic target for preeclampsia	2
New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells	2
Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	2

Bioprinting a placental model to study the effects of current and emerging treatments of preeclampsia	2
P085. Should we consider Hypertensive Disorders of Pregnancy a risk factor for postpartum haemorrhage?	2
PO1_11. Optimal timing of antenatal corticosteroid administration in pregnancies complicated by early-onset fetal growth restriction: The opticore study protocol	2
Self-monitoring blood pressure in Pregnancy: Evaluation of health professional experiences of the BUMP trials	2
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine	2
OP09_1. Prepare: a stepped wedge cluster randomised trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia	2
PO1_10. Incidence of prematurity in pregnancies complicated by hypertensive syndromes: A systematic review	2
SY8-1. Maternal diet and gut microbiota: effects on gut blood pressure and metabolism	2
Improving treatment of severe hypertension in pregnancy and postpartum using a hypertensive pathway	2
Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study	2
Y-016. Interaction between previous preeclampsia and inter-pregnancy chronic hypertension development on preeclampsia risk in the subsequent pregnancy	2
Blood pressure measurement and adverse pregnancy outcomes – Testing alternatives to 140/90 mmHg	2
Retrospective study for classifying hypertensive disorders of pregnancy by time of onset	2
P-072. Severe anemia and preeclampsia – Case report and literature review	2
Letter to the editor: Caution: Not all sFlt-1/PlGF ratios are the same	2
Preeclampsia, gestational hypertension and incident dementia: A systematic review and meta-analysis of published evidence	2
Preeclampsia prediction with blood pressure measurements: A global external validation of the ALSPAC models	2
OP06_5. Alcohol exposure prior to pregnancy - does risk consumption increase the risk of preeclampsia and low birth weight? a swedish population-based cohort study	2
Self antenatal monitoring of blood pressure at home as interVention ( SAMBHAV) in hypertensive women: Challenges in the developing country	2
P-100. Retinal microvascular oxygen saturation in women 3 years after hypertensive disorders of pregnancy	2
Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia	2
Analyses of selected tumour-associated factors expression in normotensive and preeclamptic placenta	2
SY10-2. Management of severe postpartum TMA	2
Letter to the editor: Is there a relationship between visit-to-visit blood pressure variability and adverse perinatal outcomes?	2
O-010. Annual BMI gain is associated with the risk of HDP in the subsequent pregnancy	2
Hypertension and diabetes risk in patients with previous pregnancy-related disorders and the time to onset of the disease	2
OP05_3. Time-of-disease risk prediction of adverse maternal outcomes of pre-eclampsia using artificial intelligence	1
Impact of pregnancy on hypertension and cardiovascular risks among reproductive aged Congolese women: Insights from the 2019 to 2024 May measurement month surveys	1
Factors associated with persistence of hypertension in patients with hypertensive disorders of pregnancy	1
Racial differences in healthcare utilization among patients with suspected or diagnosed preeclampsia: A retrospective cohort study	1
PO6_11. Clinical value and cost analysis of the SFLT-1/PLGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected preeclampsia: prepare cohort study	1
GS-3. Prevention and prediction of preeclampsia	1
OP19_2. Luteolin, a natural flavonoid, attenuates the development of placental ischemia-induced hypertension in pregnant rats	1
OP07_4. Aspirin treatment improves reduced uterine perfusion pressure (RUPP)-induced cardiac dysfunction in pregnant rats	1
Maternal C1q deficiency leads to impaired hemodynamic adaptations and cardiovascular dysfunction during pregnancy	1
OP04_6. The risk of new-onset neurological disorders after pregnancy-induced hypertension; a nation-wide register-based cohort study	1
P-057. Preeclampsia prediction based on urine peptidome study	1
Role of chronic kidney disease and risk factors in preeclampsia	1
Y-019. Immunomodulatory effect of vitamin D on the activators of transcription and transcription factors of CD4+ T cell subsets in pregnant women with preeclampsia	1
Editorial Board	1
Postpartum readmissions for hypertension in patients discharged on Labetalol and Nifedipine in a Tertiary Care Centre in South India	1
PO3_16. Use of magnesium sulfate in preeclampsia - main maternal side effects	1
O-007. Beneficial effect of Protease-activated receptor 2 (PAR2) on pregnancy	1
Maternal haemodynamic profile in pregnancy after assisted reproductive technology: A pilot study	1
SY1-3. Trophoblast extracellular vesicles in preeclampsia	1
P-076. Hypertensive disorder of pregnancy and gestational diabetes mellitus	1
P-086. Establishment of prediction model for hypertensive disorders of pregnancy by time series analysis	1
Y-007. Is the cut-off 38 the best value to predict adverse outcomes in pregnancies with abnormal uterine artery doppler In the second trimestre?	1
Y-008. Accurate prediction of total PlGF from free PlGF and sFlt-1: Evidence for markedly elevated PlGF levels in acute fatty liver of pregnancy	1
Reviewers	1
Pre-Eclampsia in pregnancy: A Knowledge, Attitude and Practice (KAP) Survey amongst specialists, junior residents and Primary Care Providers (PCPs) in India	1
P-070. Neonatal outcomes in pre-eclampsia: Correlation among clinical and laboratory maternal factors	1
Postpartum convulsion – An analysis	1
Clinical study of fundoscopic findings in pregnancy induced hypertension	1
PO1_07. Non proteinuric preeclampsia: Implications in the diagnosis and clinical and laboratory profile with 2013[StQuote]s new diagnostic criteria	1
PO2_10. CANCELLED: Maternal vascular malperfusion lesions and preeclampsia are associated with microvascular dysfunction, worse cognition and circulating angiogenic biomarkers 8-10 after pregnancy	1
P-080. A case of pheochromocytoma in pregnancy complicated with white coat hypertension	1
OP07_6. Hydroxychloroquine effect on endothelium – a role in the treatment of preeclampsia?	1
Title Page	1
Title Page	1
P-083. Aortic Dissection during pregnancy: A case report	1
Circulating cardiovascular biomarkers during and after preeclampsia: Crosstalk with placental function?	1
P-013. Negative predictive value of sFlt-1/PlGF ratio ≤ 38 for ruling out preeclampsia within 1–4 weeks of testing: A secondary analysis of the INSPIRE trial	1
Blood pressure adjustments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis	1
Galectin-7 dysregulates renin-angiotensin-aldosterone and NADPH oxide synthase pathways in preeclampsia	1
Elevated expression of galectin-3, thioredoxin and thioredoxin interacting protein in preeclampsia	1
P-036. Early onset hypertensive disorders of pregnancy is a high risk phenotype for placental abruption: A Japanese nationwide cohort study	1
Prognostic significance of liver function tests in predicting maternal and fetal outcomes in Hypertensive Disorders of Pregnancy	1
SY9-3. Rheumatic diseases and HDP	1
P-045. VEGFR/SFlt1 is associated to disruption of oxidative stress leading to endothelial dysfunction in preeclampsia	1
P-089. SAFE@HOME: Cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia	1
O-006. Modulatory effect of two regimens of magnesium sulfate on the systemic inflammatory response in pregnant women with eclampsia or imminent eclampsia	1
P-095. Antithrombin gamma treatment in Japanese patients with early-onset severe preeclampsia: The study protocol of a randomized phase 3 trial (KOUNO-TORI)	1
O-008. Influence of Hypertension in Pregnancy on Hematological Phenotypes of Preterm Infants with Gestational Age Inferior to 32 Weeks	1
Postpartum clinic attendance, health services utilization and cardiometabolic screening in women with preeclampsia	1
sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19	1
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia	1
The significance of mitochondrial haplogroups in preeclampsia risk	1
P-084. Symptomatic SARS-COV-2 infected pregnant patients and preeclampsia: worse outcome?	1
PO9_17. Interventions for improving subject enrollment in RCT	1
P-082. A systematic review of cardiovascular disease prevention targeting lifestyle risk factors in women. Can the evidence inform post-partum health care after hypertensive disorders of pregnancy?	1
OP06_4. Circulating concentrations of glyxocalyx degradation products in preeclampsia	1
P-054. Maternal hemodynamics assessed by USCOM® device in patients with hypertensive disorders of pregnancy during peripartum	1
Healthcare providers’ knowledge of cardiovascular disease risk after preeclampsia: A pilot of five healthcare facilities in Lusaka, Zambia	1
P-105. Probiotics supplementation increases the risk for preeclampsia	1
Preeclampsia biomarkers (sFlt-1/PlGF) dynamics are not disrupted by SARS-CoV-2 infection during pregnancy in a hypertensive disorder SARS-CoV-2 vaccinated cohort	1
P-011. sFLT-1, PLGF e sFLT-1/PLGF levels in preeclampsia: correlation with mediated maternal results	1
Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial	1
Nutricional intake, maternal outcomes and knowledge on preeclampsia prevention: Was there impact during the COVID-19 pandemic among women with hypertension?	1
PO8_7. Short-chain fatty acid producing bacteria and butyrate levels are decreased in women who develop preeclampsia throughout gestation	1
P-046. Intensive blood pressure control in chronically hypertensive mice	1
P-033. Changes of natural cytotoxicity receptors of CD56dim and CD56bright NK cells in peripheral blood and decidua in preeclampsia	1
WS-4. A multicenter prospective study of home blood pressure measurement during pregnancy in Japanese women	1
P-099. Previous preeclampsia and its association with future cardiovascular diseases: A systematic review and meta-analysis	1
P-007. Are there differences in the decidualizing endometrial secretome in women with recurrent pre-eclampsia?	1